Mycoplasma Pneumoniae: Overview of the Outbreak

• 2024

  Sign in to bookmark this resource.

  Sign in
• Larry Kociolek; Doneen West; Danielle Zerr

---

Access Resources

• SummaryEN

About

The Pediatric Pandemic Network's page on the Mycoplasma pneumoniae outbreak details a significant rise in infections, particularly among children aged 2–17, since spring 2024. It explains transmission via respiratory droplets, symptoms like cough and sore throat, and potential severe complications. The page emphasizes the importance of clinical suspicion, diagnostic testing, and treatment with macrolide antibiotics such as azithromycin. Preventive measures include hand hygiene, staying home when ill, and covering coughs and sneezes. ​

---

Tags

Focus Area: Infectious Disease

Audiences: EMS Clinicians; Nurses; Physicians; Public Health Professionals

Emergency Management Stage: Response

Keywords: Child, Preschool; Disease Outbreaks; Mycoplasma pneumoniae; Respiratory Tract Infections; Community-Acquired Infections; Disease Transmission, Infectious; Anti-Bacterial Agents; Macrolides

Institutions: Pediatric Pandemic Network (PPN)

---

More like this

BD BACTEC Blood Culture Media Shortage 2024 · Pediatric Pandemic Network (PPN) Influenza-Associated Encephalopathy or Encephalitis (IAE) and Acute Necrotizing Encephalopathy (ANE) 2025 · Pediatric Pandemic Network (PPN) H5N1 Influenza Information and Resources 2025 · Pediatric Pandemic Network (PPN), National Emerging Pathogens Training & Education Center (NETEC)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---